What is GenoPalate?
GenoPalate is a science-based nutritional genomics company dedicated to pioneering personalized nutrition. Through at-home DNA tests, one-on-one online nutrition programs guided by registered dietitians, and tailored supplement offerings, GenoPalate leverages evidence-based nutrigenomics research. The company empowers individuals to achieve optimal health by providing insights derived from their unique genetic makeup, positioning itself at the forefront of a rapidly growing market focused on data-driven wellness solutions.
How much funding has GenoPalate raised?
GenoPalate has raised a total of $9.8M across 3 funding rounds:
Series A
$4M
Other Financing Round
$5.6M
Private Equity
$250K
Series A (2020): $4M, investors not publicly disclosed
Other Financing Round (2022): $5.6M, investors not publicly disclosed
Private Equity (2026): $250K, investors not publicly disclosed
What's next for GenoPalate?
With substantial enterprise-level backing, GenoPalate is poised for significant growth and further development of its personalized nutrition platform. The strategic investment suggests a focus on scaling operations, enhancing research and development capabilities, and potentially expanding its market reach. Future initiatives are likely to center on refining its proprietary algorithms, broadening its service offerings, and solidifying its leadership in the intersection of genetics, nutrition, and digital health. The company's trajectory indicates a strong emphasis on innovation and market penetration.
See full GenoPalate company page
